By adding magnetic particles to surgical cement used to heal spinal fractures, researchers found they could guide magnetic nanoparticles directly to lesions near the fractures. The research by a team at the University of Illinois at Chicago is reported in the journal PLOS ONE.
Patients with spinal fractures caused by tumors or osteoporosis usually undergo a procedure called kyphoplasty, where the fracture is filled with surgical cement. While kyphoplasty can stabilize the bone, cancer patients are still often left with spinal column tumors that are very hard to reach with conventional chemotherapy, which has to cross the blood-brain barrier when delivered intravenously.
‘For patients with primary spinal column tumors or tumors that spread to the spinal column, a novel method of adding magnetic particles to surgical cement (used to heal spinal fractures), was used by scientists to guide magnetic nanoparticles directly to lesions near the fractures.’
Nanoparticles bound to various drugs have been used to target drugs to specific locations or types of cells in the body. Most commonly, this is achieved by binding a minute amount of drug to the nanoparticle, which is designed to also bind to a specific type of cell, such as a cancer cell.
"By modifying the kyphoplasty bone cement, we can both stabilize the spinal column and provide a targeted drug delivery system. This is a very promising technology as it has the potential to become a surgical option for patients with primary spinal column tumors or tumors that metastasize to the spinal column," said Steven Denyer, a third-year medical student in the UIC College of Medicine and a co-lead author on the paper.
Using a pig model to study the magnetically-guided drug delivery system, Denyer and colleagues were successfully able to steer magnetic nanoparticles to the magnetic cement in the animal's spinal vertebrae. In future studies to test the efficacy of this technique on treating spinal column tumors, the magnetic nanoparticles would be bound to tiny amounts of chemotherapy drugs.
"Our study provides an in vivo proof-of-concept that this novel drug delivery system can help treat underlying causes of spinal fractures in addition to providing structural support," said Abhiraj Bhimani, a fourth-year medical student in the UIC College of Medicine and a co-lead author on the paper.